Immunologic Activity Alteration Clinical Trial
Official title:
To Investigate the Immediate Effect of Birth on Immunological Parameters in Cord Blood, and Compare With Data of CS Born Infants Collected in the JULIUS SN Study
| NCT number | NCT03134768 |
| Other study ID # | CAE.1C.D.10 |
| Secondary ID | |
| Status | Completed |
| Phase | |
| First received | |
| Last updated | |
| Start date | May 2, 2016 |
| Est. completion date | October 12, 2017 |
| Verified date | April 2020 |
| Source | Danone Asia Pacific Holdings Pte, Ltd. |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Observational |
The purpose of the study is to understand the immediate effect of birth on immunological parameters in vaginally born cord blood.
| Status | Completed |
| Enrollment | 50 |
| Est. completion date | October 12, 2017 |
| Est. primary completion date | November 16, 2016 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | Female |
| Age group | N/A and older |
| Eligibility |
Inclusion Criteria: - Pregnant mothers undergoing normal vaginal delivery Exclusion Criteria: - Use of non-steroidal anti-inflammatory drugs (NSAIDs) 2 weeks prior to birth - Antenatal antibiotics treatment (2 weeks prior to birth) - Diabetes mellitus requiring insulin treatment during pregnancy - Uncontrollable Hyperthyroidism during pregnancy |
| Country | Name | City | State |
|---|---|---|---|
| n/a | |||
| Lead Sponsor | Collaborator |
|---|---|
| Danone Asia Pacific Holdings Pte, Ltd. |
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Cytokines Profile in Cord Blood Plasma | Following cytokines will be part of the profile: IL-6, IL-1, IL-2, IL-4, IL-5, IL-7, IL-8, IL-10, IL12p70, IL-13, IL-17, G-CSF, GM-CSF, IFNg, MCP-1(MCAF), MIP-1b, TNFa | 1 year | |
| Primary | Cord Blood Immunoglobulin Levels | Immunoglobulin levels will be measured in cord blood plasma | 1 year | |
| Primary | Allergen Stimulated Cytokine Expression in the Supernatants of Cord Blood Mononuclear Cells (CBMC) | Cellular response to allergen stimulation will be measured in supernatants of cultured cord blood mononuclear cells. | 1 year |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03796949 -
Threatened Preterm Birth and Time of Subsequent Delivery -a Prediction Model
|
||
| Completed |
NCT04354792 -
Asymptomatic COVID-19 Infection Among Healthcare Workers
|
||
| Terminated |
NCT01210066 -
Pain, Opioids and Pro-Inflammatory Immune Responses
|
Phase 1 | |
| Recruiting |
NCT03928431 -
Restoration of Microbiota in Neonates
|
N/A | |
| Completed |
NCT04768621 -
Health Consequences of Wintering in the French Southern and Antarctic Territories
|
N/A |